Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$213K Sell
964
-45
-4% -$11K 0.01% 711
2025
Q4
$256K Buy
1,009
+47
+5% +$11.8K 0.01% 656
2025
Q3
$238K Sell
962
-29
-3% -$6.94K 0.01% 663
2025
Q2
$238K Sell
991
-161
-14% -$37.5K 0.01% 639
2025
Q1
$261K Buy
+1,152
New +$253K 0.01% 595

Other funds holding STE

Ascent Group's STE Position: Q1 2026 in Review

Ascent Group reduced its Steris (STE) stake by 4.5% in Q1 2026, selling an estimated $11K and leaving 964 shares worth $213K. The position accounts for 0.01% of the portfolio, ranked #711.

Ascent Group first reported a position in STE in Q1 2025 and has held it in 5 quarters since. The position peaked at $261K in Q1 2025. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Ascent Group held 964 shares of Steris worth $213K as of Q1 2026.
  • Ascent Group sold 45 Steris shares in Q1 2026, an estimated $11K.
  • Steris made up 0.01% of Ascent Group's portfolio in Q1 2026, its #711 holding.
  • Ascent Group first reported a position in Steris in Q1 2025 and has held it in 5 quarters since.
  • Ascent Group's Steris position peaked at $261K in Q1 2025.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Ascent Group's 13F filing for Q1 2026, filed 15 May 2026.